Overview

Alteplase for Blood Flow Restoration in Hemodialysis Catheters

Status:
Terminated
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
We are investigating a new way of administering alteplase to remove clots from hemodialysis catheters. Currently, alteplase is left to dwell inside the catheter between dialysis treatments to dissolve the clot and restore blood flow through the catheter. We have developed a new way to administer alteplase by advancing it to the tip of the catheter at regular 10 minute intervals. We hypothesize that our new "push" protocol will dissolve clots in hemodialysis catheters better and faster than the current dwell method.
Phase:
Phase 4
Details
Lead Sponsor:
University of Manitoba
Collaborator:
Hoffmann-La Roche
Treatments:
Tissue Plasminogen Activator